常规胸腔积液及血清学检测鉴别结核性及恶性胸腔积液的临床价值
2025-07-01杜昀泽唐琼

中图分类号:R561.3 文献标志码:A DOI:10.11958/20241860
Abstract:ObjectiveTo evaluate the clinical value ofthe combination ofroutine pleural efusionand serum assay in diferentiating tuberculouspleural efusion frommalignant pleural efusion.MethodsAtotal of6Opatientswith tuberculous pleural effusionand267 patientswith malignant pleural effusionwere selectedasthestudygroup.Pleural efusionandserumlevelsoflactatedehydrogenase (LDH),adenosinedeaminase (ADA)andcarcinoembryonicantigen (CEA) were collected.Receiver operating characteristic (ROC)curve wasused to determine the diagnostic valueof pleural efusion ADA,serum LDH/pleural effusionADAandpleural efusion CEA/serum CEA intuberculouspleuralefusion,and to determine theoptimalcut-off value.Theinitialdiagnosis procedurewas designedas folows:thegroup1was definedas meeting the three conditions of pleural effusion ADA≥29.7Oo U/L,serum LDH/ pleural effusion ADA lt; 8.523 and pleural effusion CEA/ serum CEA lt;1.096 (considering tuberculous pleural effusion),patients meeting the three conditions of pleural effusion ADA lt; 29.700 U/L,serum LDH/ pleural effusion ADAgt;8.523and pleural effusion CEA/serum CEA ⩾1.096 (2 weredefiedastegroup2(malignantpleural efusionconsidered),andtheremainingonesthatdidnotmeetalloftheabove conditions were defined as the group 3.For patients in the group 3,if multinucleated cells ⩾50% in cell classification of pleural effusion,malignant pleural effusion was considered.For patients with monocytes gt;50% in cell classification of pleuraleffusion,the optimalcritical valueof ADA in pleural efusionwas determinedas34.450U/L byROCcurve.If ADAgt; 34.450 U/L,tuberculous effusion was considered.If ADA ≺ 34.450 U/L,malignant pleural effusion was considered.
According totheinitialdiagnosisprocess,151patientswith exudativepleural efusionwereselectedastheverification group.ResultsTroughtheinitialdiagnosisproces,5patientsinthestudygroupdidnotmeetthfinaldiagnosticcriteria, including3patientswithtuberculouspleural effusion(thepleural efusiondisappearedafterstandardanti-tuberculosis treatment),1patientwasfound tohavelungcancer3yearslater,lpatientwasfoundtohavecoloncancer2yearslater,and1 patient wascomplicated with ulcerativecolitis.There were2patients with malignantpleural efusion,among whom1 was pleuralmesotheliomaandtheotherwaslungadenocarcinoma.Thesensitivityand specificityof thestudygroupdiagnosed by this initial diagnostic procedure for tuberculous pleural effusion were 98.13% and 99.25% ,respectively,which were higher thanthoseusingADAaloneforpleural efusion.Afterexcluding49patients whodidnot meet thecriteriaof thisstudy102 patientswerefinallincludedintheverificationgroup,including2Ocasesoftuberculouspleural efusionand82casesof malignantpleural efusion.Through theinitialdiagnosisprocess,only2patientswith tuberculouspleuralefusionwere preliminarilydiagnosedanddidnotmetthefinaldiagnosticcriteria,including1caseofleukemiaand1caseoflymphoma. ConclusionTheinitial diagnosisprocess designed bycombiningconventionalpleural efusionand serum testshas improved the accuracy of differentiating tuberculous and malignant pleural effusion.
Keywords:tuberculosis;pleural effusion;pleural efusion,malignant;adenosinedeaminase;carcinoembryonicantigen; lactatedehydrogenase
胸腔积液中的腺苷脱氨酶(ADA)及癌胚抗原(CEA)水平对结核性及恶性胸腔积液有较高的鉴别诊断价值。结核性胸腔积液诊断标准通常为胸腔积液淋巴细胞占优势(淋巴细胞 gt;75% 和/或淋巴细胞中性粒细胞 gt;0.75 且 ADAgt;40U/L[1-2] 。但随着人口老龄化、结核病及恶性肿瘤发病率的升高,使用当前ADA截断值进行鉴别可能会导致误诊[3]。同时恶性胸腔积液CEA水平敏感度仅为 29%~77%[4-5] 。乳酸脱氢酶(LDH)在无氧糖酵解途径中通过介导产生腺苷三磷酸(ATP),肿瘤细胞优先通过此途径产生能量,故肿瘤患者血清LDH水平经常升高[2]。本研究通过对明确诊断的结核性及恶性胸腔积液患者的胸腔积液及血清学指标进行分析,探讨能否通过创建的诊断流程提高初步诊断的准确率。
1对象与方法
1.1研究对象选取2013年1月一2022年5月在人民医院呼吸科确诊为结核性及恶性胸腔积液患者427例作为研究组,其中男262例、女165例,年龄15\~94岁,平均( 65.60± 19.75)岁。本研究获得我院医学伦理委员会批准(批准号:201809010),患者均自愿接受电话随访并签署知情同意书。1.2诊断标准结核性胸腔积液断符合以下1个或多个标准[6:(1)痰涂片发现抗酸杆菌,抗结核治疗后胸腔积液消退。(2)胸腔镜及经皮穿刺肺活检病理确诊。(3)临床确诊,完全满足胸腔积液细胞分类中单核细胞 gt;50%.ADAgt;40U/L, 结核感染T细胞培养阳性3个条件的患者初步诊断为结核性胸腔积液。并在2022年3一5月对所有初步诊断为结核性胸腔积液至少1年的患者逐一通过电话随访的方式询问病情进展及抗结核治疗效果,若符合经抗结核治疗后胸腔积液消退则为临床确诊;……
